 |
Visterra
Last updated: April 15, 2024
Kevin Bitterman, Founder
Country: USA | Funding: $125.4M (+)
Website: http://www.visterrainc.com
Visterra is a clinical-stage biopharmaceutical company focused on applying its novel Hierotope platform to identify unique disease targets and to design and engineer precision antibody-based biological medicines for infectious and non-infectious diseases.
Website: http://www.visterrainc.com
Visterra is a clinical-stage biopharmaceutical company focused on applying its novel Hierotope platform to identify unique disease targets and to design and engineer precision antibody-based biological medicines for infectious and non-infectious diseases.
